Ultragenyx Pharmaceutical Inc. · NASDAQ:RARE
State Street Corp reported a 5.10% stake in Ultragenyx Pharmaceutical Inc. (Schedule 13G)
Event Mar 31, 2026 · Filed May 12, 2026
State Street Corp reported a 5.10% stake in Ultragenyx Pharmaceutical Inc., 5,021,441 shares, as a passive investor on Mar 31, 2026. Filed May 12, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 5,021,441
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| STATE STREET CORPORATION | 5.10% | 5,021,441 |
Source
Related
- Ultragenyx Pharmaceutical Inc.
- State Street Corp
- Ultragenyx Pharmaceutical Inc. shareholders
- Schedule 13G · State Street Corp · Aug 7, 2026
- Schedule 13G · Madison Avenue Partners, LP · Oct 20, 2026
- Form 4 · Horn Howard · Oct 19, 2026
- Form 4 · Huizenga Theodore Alan · Sep 15, 2026
- Form 4 · Huizenga Theodore Alan · Sep 8, 2026
- Schedule 13G · Rtw Investments, LP · Aug 14, 2026